US 8431532
FZD8 extracellular domains and FZD8 extracellular domain fusion molecules and treatments using same
granted A61KA61K38/17A61P
Quick answer
US patent 8431532 (FZD8 extracellular domains and FZD8 extracellular domain fusion molecules and treatments using same) held by Five Prime Therapeutics, Inc. expires Mon Apr 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Five Prime Therapeutics, Inc.
- Grant date
- Tue Apr 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K38/17, A61P, A61P11/00, A61P19/08